Rapport Therapeutics Stock Quote RAPP - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

19.07

Bid

18.40

Ask

20.40

Volume

109,329

18.29 Day's Range 19.855

16.55 52 Week Range 29.74

Market Cap

697.513M

Previous Close

18.56

Open

18.41

Last Trade

297

19.07

(priorref)

Last Trade Time

Financial Volume

$ 2,079,649

VWAP

19.0219

Average Volume (3m)

111,251

Shares Outstanding

36,576,457

Dividend Yield

PE Ratio

-19.83

Earnings Per Share (EPS)

-0.95

Revenue

Net Profit

-34.79M

Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational sma... Rapport Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule medicines for patients suffering from central nervous system (CNS) disorders. Its lead product candidate is receptor associated protein (RAP)-219, an investigational small molecule that is designed to inhibit TARPy8-containing AMPARs with picomolar affinity for the treatment of focal epilepsy and other CNS disorders, including peripheral neuropathic pain and bipolar disorder. The company also develops RAP-199, a TARPy8 targeted molecule with differentiated chemical and pharmacokinetic properties; and nicotinic acetylcholine receptor (nAChR) programs, such as a6 nAChR to treat chronic pain and a9a10 nAChR for the treatment of hearing disorders. Rapport Therapeutics, Inc. was incorporated in 2022 and is headquartered in Boston, Massachusetts. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Headquarters

New Castle, Delaware, USA

Founded

Rapport Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RAPP. The last closing price for Rapport Therapeutics was $18.56. Over the last year, Rapport Therapeutics shares have traded in a share price range of $ 16.55 to $ 29.74.

Rapport Therapeutics currently has 36,576,457 shares outstanding. The market capitalization of Rapport Therapeutics is $678.86 million. Rapport Therapeutics has a price to earnings ratio (PE ratio) of -19.83.

Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical Seizures

A 30% reduction in long episodes was shown to be associated with a 50% or greater reduction in clinical seizures in a post-hoc analysis, validating the biomarker for proof-of-concept studies...

Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit

BOSTON and SAN DIEGO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.16	-5.73405832921	20.23	21.15	17.79	171325	19.66068686	CS
4	-2.41	-11.2197392924	21.48	24.49	17.79	124824	21.08479838	CS
12	-0.97	-4.84031936128	20.04	29.74	17.79	111251	22.4082075	CS
26	-6.66	-25.8841818888	25.73	29.74	16.55	145834	22.0771957	CS
52	1.07	5.94444444444	18	29.74	16.55	156600	22.11388182	CS
156	1.07	5.94444444444	18	29.74	16.55	156600	22.11388182	CS
260	1.07	5.94444444444	18	29.74	16.55	156600	22.11388182	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUKKNukkleus Inc	$ 11.655 (738.49%)	174.4M
PRTGPortage Biotech Inc	$ 8.8678 (172.86%)	36.61M
OPTXSyntec Optics Holdings Inc	$ 3.55 (99.44%)	93.16M
PTPIPetros Pharmaceuticals Inc	$ 0.4976 (86.37%)	63.49M
LUXHLuxUrban Hotels Inc	$ 0.849899 (59.67%)	29.52M
VCNXVaccinex Inc	$ 1.41 (-61.37%)	744.49k
TNYATenaya Therapeutics Inc	$ 1.395 (-51.56%)	42.02M
ORKTOrangeKloud Technology Inc	$ 2.14 (-41.85%)	2.29M
RVPHReviva Pharmaceuticals Holdings Inc	$ 1.395 (-39.35%)	17.77M
DBGIDigital Brands Group Inc	$ 2.46 (-37.88%)	787.17k
RIMEAlgorhythm Holdings Inc	$ 0.0877 (8.27%)	1.13B
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.335 (-36.79%)	1B
GOEVCanoo Inc	$ 0.118 (7.08%)	382.65M
NVDANVIDIA Corporation	$ 130.39 (-1.22%)	251.69M
XTIAXTI Aerospace Inc	$ 0.0442 (8.33%)	221.38M